Scholarly Index
Paul Bastard
Inserm; 13,055 total citations; 138 total publications; best world rank #15
Inserm
13,055Total citations
138Total publications
52H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| COVID-19 Clinical Research Studies | Lifetime | 359 | FR 18 | 98.48 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 606 | FR 20 | 98.04 |
| Long-Term Effects of COVID-19 | Lifetime | 573 | FR 31 | 96.00 |
| COVID-19 Clinical Research Studies | 2021-2025 | 54 | FR 1 | 99.61 |
| interferon and immune responses | 2021-2025 | 15 | FR 2 | 98.32 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 129 | FR 5 | 99.37 |
| Immunodeficiency and Autoimmune Disorders | 2021-2025 | 26 | FR 3 | 99.10 |
| Long-Term Effects of COVID-19 | 2021-2025 | 208 | FR 9 | 97.52 |
| Diabetes and associated disorders | 2021-2025 | 421 | FR 7 | 91.78 |
| Blood disorders and treatments | 2021-2025 | 138 | FR 11 | 88.52 |
| T-cell and B-cell Immunology | 2021-2025 | 895 | FR 36 | 85.32 |
| Kawasaki Disease and Coronary Complications | 2021-2025 | 353 | FR 10 | 82.38 |
| Adrenal Hormones and Disorders | 2021-2025 | 537 | FR 26 | 74.36 |